Related Experiment Video

Updated: Aug 8, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

[Prevention of thromboembolism in patients with atrial fibrillation]

M Schmidt1, J Brömsen, M Blumenstein

  • 1Stiftsklinik Augustinum, München. Schmidt@med.augustinum.de

MMW Fortschritte Der Medizin
|May 23, 2006
PubMed

Insights

Effective anticoagulation significantly benefits patients with chronic atrial fibrillation, reducing thromboembolic risks. Guidelines may expand to recommend long-term anticoagulation, even after rhythm restoration, with hopes for safer, simpler drugs.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Chronic atrial fibrillation poses a significant risk of thromboembolic complications.
  • Current therapeutic guidelines for anticoagulation in atrial fibrillation are established but may evolve.

Purpose of the Study:

  • To emphasize the therapeutic benefits of effective anticoagulation in chronic atrial fibrillation.
  • To discuss potential expansions of current therapeutic guidelines for anticoagulation.
  • To highlight the need for safer and simpler anticoagulation therapies.

Main Methods:

  • Review of existing therapeutic guidelines and criteria for anticoagulation in atrial fibrillation.
  • Analysis of the impact of anticoagulation on thromboembolic complications.
  • Discussion of the role of vitamin K antagonists and future drug development.

Main Results:

  • Effective anticoagulation is crucial for managing chronic atrial fibrillation patients.
  • Anticoagulation treatment with vitamin K antagonists may be recommended long-term, even post-sinus rhythm restoration.
  • There is an ongoing need for anticoagulants with predictable safety and ease of administration.

Conclusions:

  • Anticoagulation therapy is indispensable for patients with chronic atrial fibrillation.
  • Therapeutic guidelines are likely to be updated to further minimize thromboembolic events.
  • Future advancements aim to provide safer and more convenient anticoagulation options.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...